[COMPLEMENT ACTIVITY IN PATIENTS CONVALESCING FROM TYPHOID FEVER SUBJECTED TO ANTITYPHOID VACCINATION AND TREATED WITH 4-HYDROXY-19-NORTESTOSTERONE-17-CYCLOPENTYL-PROPIONATE].
D045930:Anabolic Agents; D003165:Complement System Proteins; D004358:Drug Therapy; D006801:Humans; D009277:Nandrolone; D011422:Propionates; D013256:Steroids; D045165:Testosterone Congeners; D014435:Typhoid Fever; D014436:Typhoid-Paratyphoid Vaccines; D014611:Vaccination
D045930:Anabolic Agents; D011422:Propionates; D013256:Steroids; D045165:Testosterone Congeners; D014436:Typhoid-Paratyphoid Vaccines; D009277:Nandrolone; D003165:Complement System Proteins
ANABOLIC STEROIDS; COMPLEMENT; DRUG THERAPY; TYPHOID; TYPHOID-PARATYPHOID VACCINES
ATTIVIT'A COMPLEMENTARE IN CONVALESCENTI D'ILEOTIFO SOTTOPOSTI ALLA VACCINAZIONE ANTITIFICA E TRATTATI CON 4-IDROSSI-19-NORTESTOSTERONE-17-CICLOPENTILPROPIONATO.